Ataluren for the treatment of people living with nonsense mutation Duchenne muscular dystrophy: a plain language summary of Study 041. [PDF]
Wu S +3 more
europepmc +1 more source
Survey of Adrenal Insufficiency Management for Duchenne muscular dystrophy in Italy. [PDF]
Tornese G +6 more
europepmc +1 more source
Early Cardiac Manifestations as the Initial Presentation of Duchenne Muscular Dystrophy in Infancy. [PDF]
Shatarat F +3 more
europepmc +1 more source
Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: Clinical practice recommendations [PDF]
Bowden, Sasigarn A +3 more
core +1 more source
Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. [PDF]
Aminzadeh MA +15 more
europepmc +1 more source
An Assessment of Paediatricians' Knowledge and Perspectives of Duchenne Muscular Dystrophy in Oman. [PDF]
Al Jabri Z +4 more
europepmc +1 more source
Duchenne Muscular Dystrophy: Contemporary Therapeutic Options and Real-World Challenges in Treatment Selection. [PDF]
Pesco MT +5 more
europepmc +1 more source
State-of-the-Art Research and New Pharmacological Perspectives on Renal Involvement in Duchenne Muscular Dystrophy: A Narrative Review. [PDF]
Bellis M +4 more
europepmc +1 more source
Clinico-genetic heterogeneity in Pakistani families affected with muscular dystrophies. [PDF]
Ahmad R +5 more
europepmc +1 more source
Neonatal screening for Duchenne muscular dystrophy in eastern China: a closed prospective study. [PDF]
Qian G +5 more
europepmc +1 more source

